The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Valaciclovir Bluefish 500 mg film-coated tablets

500 milligram(s) Film-coated tablet

Bluefish Pharmaceuticals AB PA1436/005/001

Main Information

Trade NameValaciclovir Bluefish 500 mg film-coated tablets
Active SubstancesValaciclovir hydrochloride monohydrate
Strength500 milligram(s)
Dosage FormFilm-coated tablet
Licence HolderBluefish Pharmaceuticals AB
Licence NumberPA1436/005/001

Group Information

ATC CodeJ05AB Nucleosides and nucleotides excl. reverse transcriptase inhibitors
J05AB11 valaciclovir


Licence Issued28/08/2009
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back